Cite Filings / IMNM / 0001415889-25-002988

Feed Companies Filings Check

Sign in

SCHEDULE 13D/A

Beneficial Ownership Report

Immunome Inc. Filed 2025-02-04 Acc 0001415889-25-002988

Documents 1

SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

2025-12-22 SCHEDULE 13D/A Beneficial Ownership Report
2025-02-04 SCHEDULE 13D/A Beneficial Ownership Report
2025-02-03 4 President and CEO bought 150,000 shares at $7.75 ($1,162,500)
2025-02-03 SCHEDULE 13G Statement of Beneficial Ownership
2025-01-30 8-K Other events
2025-01-30 424B5 Prospectus
2025-01-30 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…